Catenae Innovation PLC Cov-ID Project Update (4377Q)
19 Junio 2020 - 01:00AM
UK Regulatory
TIDMCTEA
RNS Number : 4377Q
Catenae Innovation PLC
19 June 2020
Catenae Innovation PLC
("Catenae", or the "Company")
Cov-ID Project Update
Further to the announcement on 29 May 2020, Catenae Innovation
PLC (AIM: CTEA), the AIM quoted provider of digital media and
technology, announces that its occupational health and wellness
partner, Newcastle Premier Health Limited ("NPH") has completed the
proof of concept pilot trial of the Company's Cov-ID app (the
"Cov-ID Project").
NPH provided its clinical expertise to the Cov-ID Project and
has been piloting the app since 29 May 2020.
The Cov-ID app is a COVID-19 status verification passport,
designed to support the efforts of businesses and organisations in
getting back to work, whilst safeguarding employees from the spread
of COVID-19 by allowing the user ("Certificate Holder") to share
and prove their COVID-19 status in a secure, immutable and GDPR
compliant manner.
The objective of the pilot trial was to undertake a "proof of
concept" of the app to determine that user management,
certification management and user validation achieved their
functionality targets which included, inter alia - importing,
creating and archiving certificate and user data and viewing data
via secure means through both one-way and two-way validation
processes.
Both the one-way and two-way validation processes work across
Android and iOS platforms.
The app allows a Certificate Holder to expose their COVID -19
anti-body testing status to a third-party "gate-keeper" via a
single use QR code displayed on their device.
In one-way validation, the QR code is readable by any device
equipped with QR scanner functionality or app. In two-way
validation mode both the gate-keeper and the Certificate Holder use
the app allowing the identity of the gate-keeper to be validated
and restricting the display of the Certificate Holder's status
solely to the gate-keeper. Additionally the event is logged and
recorded to a blockchain repository.
The Cov-ID project is a joint initiative by a consortium of
companies led by the Z/Yen Group.
Although the proof of concept stage of the app has been
positive, there is no guarantee that it will be commercialised, nor
that in the event that it is commercialised, that material revenues
will be generated by the Company.
Guy Meyer, Interim Chief Executive Officer of Catenae, said: "We
are really pleased that NPH has completed the proof of concept in
the Company's Cov-ID Project. The scope of the pilot trial was
ambitiously expanded midway through to include the one-way
validation usage on top of the initial two-way validation usage
objective. Some minor graphic design refinements, based on NPH's
feedback, will be completed within the next three weeks and then
the Cov-ID app will be ready to be rolled out commercially across
the UK and beyond to the benefit of businesses and organisations
alike as the nations of the world begin to return to a semblance of
normality.
I look forward to updating the market with further progress
shortly."
Mark Philpott, Managing Director of Newcastle Premier Health
Limited said: "We are pleased that the Cov-ID app performed well as
part of our 'Controlled Access and Testing Programme', a carefully
structured 'return to work pathway', which will give our business
clients and their employees the reassurance they need when entering
the workplace."
This announcement contains inside information for the purposes
of Article 7 of EU Regulation 596/2014. The person who arranged for
release of this announcement on behalf of the Company was Guy
Meyer, Interim Chief Executive Officer of the Company.
- Ends -
For further information please contact:
+44 (0)191 580
Catenae Innovation PLC 8545
Guy Meyer, Interim CEO
Cairn Financial Advisers LLP (Nominated Adviser) +44(0)20 7213 0880
Liam Murray / Jo Turner
+44 (0)20 3463
Brandon Hill Capital Limited, Broker 5000
Andy Gutmann +44 (0)78796 8313
+44 (0)20 3004
Yellow Jersey PR (PR & IP) 9512
Sarah Hollins / Annabel Atkins
Notes to Editors:
About Catenae Innovation PLC
Catenae Innovation is an AIM quoted provider of digital media
and technology services. The Company specialises in Distributed
Ledger Technology solutions that solve commercial challenges and
create opportunities for its clients. The Company has an
experienced IT team of project managers and integrators who have
deployed systems across corporate, government and educational
sectors.
www.catenaeinnovation.com
About NPH Group
The NPH Group are a leading healthcare provider based in the
North East of England. NPH offer COVID -19 strategic consultancy to
global clients and UK testing services nationally. In addition to a
full range of professional Occupational Health and Wellbeing
services, they help businesses and organisations achieve their
strategic personnel goals, ensuring business remain compliant and
productive.
www.newcastlepremierhealth.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
UPDEAEKPFALEEAA
(END) Dow Jones Newswires
June 19, 2020 02:00 ET (06:00 GMT)
Catenae Innovation (LSE:CTEA)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024
Catenae Innovation (LSE:CTEA)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024